Skip to main content
. 2021 Aug 3;11:15701. doi: 10.1038/s41598-021-95209-x

Figure 2.

Figure 2

Detection of plasma markers GAS6 and sAXL. Plasma from COVID-19 IC patients (n = 100), non-COVID-19 IC patients (n = 11), and healthy controls (n = 15) was tested for the presence of GAS6 (A), and sAXL (B) at ICU admission. P-values were calculated with the Kruskal–Wallis test with Dunn’s post-hoc test. P-value were considered significant if p < 0.05; * 0.05, ** 0.01, *** 0.001. Statistical analysis of the three groups were p < 0.001 for Gas6 (A), and p = 0.134 for sAXL (B).